The Spanish Agency has released some recommendations in order to facilitate that drug distributors comply with specific obligations, related to the detection, investigation and notification of unusual sales patterns. This document concerns the need to put in place a specific procedure to communicate unusual sales that may constitute a diversion or misuse of medicines. More info at: https://bit.ly/2IXgEfi